Clinical trial · Interventional
Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment
Cost-effectiveness of EndWarts® FREEZE for Wart Treatment: A Randomized, Controlled, Investigator-Blinded, Comparative Study
NCT04781244CI-TRIAL-00075186completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to study cost-effectiveness of EndWarts® FREEZE for wart treatment, compared to conventional liquid nitrogen cryotherapy
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cryotherapy Effect | — | UNRESOLVED | — |
| Warts | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EndWarts® FREEZE | Device | — | UNRESOLVED |
| Liquid nitrogen | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- ACTIVE_COMPARATOR
- label
- EndWarts® FREEZE in Soft keratin
- description
- EndWarts® FREEZE were treated to 11 patients with wart at soft keratin
- interventionNames
- Device: EndWarts® FREEZE
- type
- ACTIVE_COMPARATOR
- label
- EndWarts® FREEZE in Hard keratin
- description
- EndWarts® FREEZE were treated to 11 patients with wart at hard keratin
- interventionNames
- Device: EndWarts® FREEZE
- type
- ACTIVE_COMPARATOR
- label
- Liquid nitrogen in Soft keratin
- description
- Liquid nitrogen were treated to 11 patients with wart at soft keratin
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of plantar or common wart at Department of Dermatology, Siriraj hospital Exclusion Criteria: * Patient with more than 5 warts or wart more than 1 cm in diameter * Wart at face, genitalia, scalp, joint * Pregnancy or breastfeeding patient * Wart with wound/irritation or local infection * Diabetes mellitus patients or patients with coagulopathies or cryoglobulinemia * Immunocompromised host or on immunosuppressive drug * Received any treatment in previous 3 months before inclusion
References
Publications (5)
- RESULTWalczuk I, Eertmans F, Rossel B, Cegielska A, Stockfleth E, Antunes A, Adriaens E. Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment: A Randomized, Controlled, Investigator-Blinded, Comparative Study. Dermatol Ther (Heidelb). 2018 Jun;8(2):203-216. doi: 10.1007/s13555-017-0210-5. Epub 2017 Dec 6. PMID 29214505
- RESULTGhadgepatil SS, Gupta S, Sharma YK. Clinicoepidemiological Study of Different Types of Warts. Dermatol Res Pract. 2016;2016:7989817. doi: 10.1155/2016/7989817. Epub 2016 Mar 7. PMID 27047542
- RESULTLipke MM. An armamentarium of wart treatments. Clin Med Res. 2006 Dec;4(4):273-93. doi: 10.3121/cmr.4.4.273. PMID 17210977
- RESULTSterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014 Oct;171(4):696-712. doi: 10.1111/bjd.13310. Epub 2014 Oct 1. No abstract available. PMID 25273231
- RESULTBruggink SC, Gussekloo J, Berger MY, Zaaijer K, Assendelft WJ, de Waal MW, Bavinck JN, Koes BW, Eekhof JA. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. CMAJ. 2010 Oct 19;182(15):1624-30. doi: 10.1503/cmaj.092194. Epub 2010 Sep 13. PMID 20837684